Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

Development of immunotherapy in China

Prof Yi-Long Wu - Guangdong General Hospital, China

Development of immunotherapy in China ( Prof Yi-Long Wu - Guangdong General Hospital, China )

Combining radiotherapy with immunotherapy

Dr James Welsh - MD Anderson Cancer Center, Houston, USA

Combining radiotherapy with immunotherapy ( Dr James Welsh - MD Anderson Cancer Center, Houston, USA )

Biomarker driven clinical trials

Dr Oleg Gluz - West German Study Group Monchengladbach, Germany

Biomarker driven clinical trials ( Dr Oleg Gluz - West German Study Group Monchengladbach, Germany )

Decoding breast cancer predisposition genes

Dr Fergus Couch - Mayo Clinic, Rochester, USA

Decoding breast cancer predisposition genes ( Dr Fergus Couch - Mayo Clinic, Rochester, USA )

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark

Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )

Matched mutations and long term letrozole for breast cancer

Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA

Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

TCHP with/out oestrogen for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA

TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )

Whole exome and transcriptome sequencing of resistant ER positive metastatic...

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

More from ecancer